SA
Sign upLog In
ARWR

ARWR Common Stock Issued

$303.95MTTM · USD

Period ending:

AnnualQuarterlyTTMChart Studio →
ARWR FY Common Stock IssuedUSD
ARWR FY Common Stock Issued1997-09-30: $0.001998-09-30: $0.001999-09-30: $0.002000-09-30: $0.002001-09-30: $0.002002-09-30: $0.002003-09-30: $4.68K2004-09-30: $9.87M2005-09-30: $20.74M2006-09-30: $20.89M2007-09-30: $15.59M2008-09-30: $16.27M2009-09-30: $2.76M2010-09-30: $12.17M2011-09-30: $6.23M2012-09-30: $10.89M2013-09-30: $42.45M2014-09-30: $172.64M2015-09-30: $0.002016-09-30: $52.23M2017-09-30: $12.42M2018-09-30: $56.59M2019-09-30: $60.52M2020-09-30: $250.48M2021-09-30: $0.002022-09-30: $5.19M2023-09-30: $3.05M2024-09-30: $431.65M2025-09-30: $270.37M$431.65M$0.00
1997-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ARWR common stock issued history

Cash received from issuing common stock. The available annual fiscal periods series contains 29 observations from Sep 30, 1997 to Sep 30, 2025.

Arrowhead Pharmaceuticals Inc Common Stock Issued — Annual fiscal periods (USD)
Period endingCommon Stock Issued (USD)
270,371,000
431,654,000
3,053,000
5,186,000
0
250,479,000
60,522,000
56,585,035
12,419,119
52,231,433
0
172,641,671
42,448,826
10,891,992
6,226,321
12,165,156
2,758,993
16,272,911
15,586,942
20,886,537
20,744,335
9,871,415
4,680
0
0
0
0
0
0

Compare common stock issued

All ARWR financial metrics · ARWR stock overview · How to interpret financial metrics

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.